A detailed history of Nations Financial Group Inc, transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Nations Financial Group Inc, holds 10,000 shares of NVCT stock, worth $50,199. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$50,199
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$6.16 - $7.23 $61,600 - $72,300
10,000 New
10,000 $62,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $73.5M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Nations Financial Group Inc, Portfolio

Follow Nations Financial Group Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.